Zobrazeno 1 - 10
of 501
pro vyhledávání: ''
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Publikováno v:
Int J Cancer
High nut consumption is associated with reduced total and certain cause-specific mortality in general populations. However, its association with cancer outcomes among long-term breast cancer survivors remains unknown. We examined the associations of
Autor:
Anna Z. de Boer, Esther Bastiaannet, Johannes Schetelig, Nienke A. de Glas, Damjan Manevksi, Hein Putter, Gerrit Jan Liefers, Linda de Munck, Johanneke E.A. Portielje, Liesbeth C. de Wreede
Publikováno v:
European Journal of Cancer, 174, 212-220. ELSEVIER SCI LTD
Introduction: In older patients with breast cancer, the risk of dying from other causes than breast cancer strongly increases after the age of 70. The aim of this study was to assess contributions of breast cancer mortality versus other-cause mortali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c7039c916034f897c4a80f786159693
https://hdl.handle.net/1887/3564245
https://hdl.handle.net/1887/3564245
Autor:
Momal Chand, Valentina Hoyos, Jason A Mouabbi, Daniel Ockner, Mothaffar F. Rimawi, Amr Aref, Tarik Hadid, Ramen Sakhi, Carrie L. Dul, Ishaq A. Asghar
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4790-4795 (2021)
Cancer Medicine
Cancer Medicine
Objective The goal was to compare the 5‐year DFS and 5‐year OS in patients with early‐stage human epidermal growth factor receptor 2 breast cancer (HER2+ BC) and triple‐negative breast cancer (TNBC) in relation to the amount of stromal tumor
Autor:
Giacomo Montagna, Monica Morrow
Publikováno v:
Clinical Breast Cancer. 21:112-119
Radiotherapy (RT) after breast-conserving surgery (BCS) halves the risk of local recurrence, and it is considered the standard of care for the vast majority of patients with early invasive breast cancer. However, the majority of patients treated with
Autor:
Susan Abughosh, Meghana V. Trivedi, Kelvin Lu, Rutugandha Paranjpe, Carine Opsomer, Hanna Zaghloul, Grace S. Hwang, Uzoamaka Abajue
Publikováno v:
Clinical Breast Cancer. 20:520-526
Introduction Adherence to oral endocrine therapy (OET) reduces recurrence risk for hormone receptor (HR)-positive breast cancer (BC). Refill data accessed through electronic health records may provide objective assessment of OET adherence. Our goal w
Publikováno v:
Clinical and Translational Oncology. 23:526-535
Reduction of surgeries in axillary has been proved feasible in breast cancer with negative and limited involved axillary lymph nodes. However, for women with a heavy axillary burden, the extent of dissection is still arguable. From a total of 7042 pa
Publikováno v:
Breast Cancer Research and Treatment. 182:411-420
Women over 70 with early breast cancer treated with breast-conserving surgery are typically offered adjuvant endocrine and radiation therapy. Prior studies have supported the omission of adjuvant radiation in this low-risk population. We sought to co
Autor:
Tuya Pal, Christina E. Bailey, Wei Zheng, Ingrid A. Mayer, Xiao-Ou Shu, Ingrid M. Meszoely, Ben Ho Park, Fei Wang, Sonya Reid
Publikováno v:
Clin Cancer Res
Purpose: Prognostic value of Oncotype DX Breast Recurrence Score (RS) in male patients with breast cancer is understudied. We evaluated associations of RS with overall mortality in male patients with breast cancer and compared it with female counterp
Autor:
Verena Kainz, Christian F. Singer, Florian Fitzal, Margaretha Rudas, Martin Filipits, Peter Regitnig, Michael Gnant, Zsuzsanna Bago-Horvath, Stephen Barron, Richard Greil, Marija Balic, Dominik Hlauschek, William M. Gallagher, Tony Loughman, Des O'Leary, Stefan Halper, Wolfgang Hulla, Peter Dubsky, Daniel Egle
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(21)
Purpose: To validate the clinical performance of the OncoMasTR Risk Score in the biomarker cohort of Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 8. Experimental Design: We evaluated the OncoMasTR test in 1,200 formalin-fixed, para